Showing 1 - 20 results of 21 for search 'Gregory J Dore', query time: 0.48s
Refine Results
-
1
Hepatitis C virus incidence among injecting drug users on opioid replacement therapy by Richard Hallinan, Andrew Byrne, Janaki Amin, Gregory J. Dore
Published 2004-12-01
Article -
2
-
3
-
4
Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia by Mohammad T. Yousafzai, Maryam Alavi, Heather Valerio, Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore
Published 2022-07-01
Article -
5
Late HIV presentation among AIDS cases in Australia, 1992–2001 by Ann M. McDonald, Yueming Li, Gregory J. Dore, Hugo Ree, John M. Kaldor
Published 2003-12-01
Article -
6
-
7
-
8
-
9
Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications. by Jisoo A Kwon, Gregory J Dore, Behzad Hajarizadeh, Maryam Alavi, Heather Valerio, Jason Grebely, Rebecca Guy, Richard T Gray
Published 2021-01-01
Article -
10
Survival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000‐2014) by Reem Waziry, Jason Grebely, Janaki Amin, Maryam Alavi, Behzad Hajarizadeh, Jacob George, Gail V. Matthews, Matthew Law, Gregory J. Dore
Published 2017-10-01
Article -
11
-
12
Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales by Syed Hassan Bin Usman Shah, Maryam Alavi, Behzad Hajarizadeh, Gail V. Matthews, Marianne Martinello, Mark Danta, Janaki Amin, Matthew G. Law, Jacob George, Heather Valerio, Gregory J. Dore
Published 2022-10-01
Article -
13
Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study by Marianne Martinello, Sanjay Bhagani, David Shaw, Chloe Orkin, Graham Cooke, Edward Gane, David Iser, Andrew Ustianowski, Ranjababu Kulasegaram, Catherine Stedman, Elise Tu, Jason Grebely, Gregory J. Dore, Mark Nelson, Gail V. Matthews
Published 2023-10-01
Article -
14
Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study by Anna Conway, Phillip Read, Rosie Gilliver, Tony McNaughton, Heather Valerio, Evan B. Cunningham, Charles Henderson, Brett Hadlow, Katrina Molloy, Anna Doab, Shane Tillakeratne, Lucy Pepolim, Mary Ellen Harrod, Gregory J. Dore, Jason Grebely
Published 2022-11-01
Article -
15
High Effectiveness of Broad Access Direct‐Acting Antiviral Therapy for Hepatitis C in an Australian Real‐World Cohort: The REACH‐C Study by Jasmine Yee, Joanne M. Carson, Behzad Hajarizadeh, Joshua Hanson, James O’Beirne, David Iser, Phillip Read, Anne Balcomb, Joseph S. Doyle, Jane Davies, Marianne Martinello, Philiipa Marks, Gregory J. Dore, Gail V. Matthews, the REACH‐C Study Group
Published 2022-03-01
Article -
16
The kynurenine pathway relates to post‐acute COVID‐19 objective cognitive impairment and PASC by Lucette A. Cysique, David Jakabek, Sophia G. Bracken, Yasmin Allen‐Davidian, Benjamin Heng, Sharron Chow, Mona Dehhaghi, Ananda Staats Pires, David R. Darley, Anthony Byrne, Chansavath Phetsouphanh, Anthony Kelleher, Gregory J. Dore, Gail V. Matthews, Gilles J. Guillemin, Bruce J. Brew
Published 2023-08-01
Article -
17
Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct‐acting antiviral era: A molecular epidemiology study am... by Sofia R. Bartlett, Andrey Verich, Joanne Carson, Samira Hosseini‐Hooshyar, Phillip Read, David Baker, Jeffrey J. Post, Robert Finlayson, Mark Bloch, Joseph S. Doyle, David Shaw, Margaret Hellard, Maria Martinez, Philippa Marks, Gregory J. Dore, Gail V. Matthews, Tanya Applegate, Marianne Martinello
Published 2022-09-01
Article -
18
Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance by Mark W. Douglas, Enoch S.E. Tay, Dao Sen Wang, Adrian T.L. Ong, Caroline Wilson, Amy Phu, Jen Kok, Dominic E. Dwyer, Rowena A. Bull, Andrew R. Lloyd, Tanya L. Applegate, Gregory J. Dore, Anita Y. Howe, Richard Harrigan, Jacob George
Published 2020-06-01
Article -
19
Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study by Joanne M. Carson, Sebastiano Barbieri, Evan Cunningham, Eric Mao, Marc van derValk, Jürgen K. Rockstroh, Margaret Hellard, Arthur Kim, Sanjay Bhagani, Jordan J. Feld, Ed Gane, Maria C. Thurnheer, Julie Bruneau, Elise Tu, Gregory J. Dore, Gail V. Matthews, Marianne Martinello, the REACT study group
Published 2023-09-01
Article -
20
A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake amo... by Anna Conway, Heather Valerio, Maryam Alavi, David Silk, Carla Treloar, Behzad Hajarizadeh, Alison D. Marshall, Marianne Martinello, Andrew Milat, Adrian Dunlop, Carolyn Murray, Bianca Prain, Charles Henderson, Janaki Amin, Phillip Read, Pip Marks, Louisa Degenhardt, Jeremy Hayllar, David Reid, Carla Gorton, Thao Lam, Michael Christmass, Alexandra Wade, Mark Montebello, Gregory J. Dore, Jason Grebely
Published 2022-07-01
Article